Clinical Research Department
Megapharm has formed a dedicated Clinical Research Department offering the possibility of early phase clinical research studies. Studies in Israel are fully recognized by all international health and licensing authorities, including the FDA.
Clinical studies are conducted on behalf of our business partners for the products to be marketed by Megapharm.
We also offer clinical research services providing clinical monitoring, regulatory guidance, safety reporting, drug import and storage. Megapharm CRAs operate according to GCP and ICH guidelines.
Megapharm, in its strategy of concentrating on innovative approaches and products in the biotech area, is involved in a number of clinical Phase II and III research projects.
The cross-functional teams of Megapharm enable us to be selective and accurate in choosing suitable centers for specific clinical trials. This helps companies to make feasible and informed decisions and dramatically shortens the time it takes to set up the study sites.
Megapharm also provides consultation and supervision services to our partners and future business associates on clinical studies in Israel.